Shr-A1811: Clinical Trials

1 trial of Shr-A1811, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Shr-A1811: new trials by email Literature Review of Shr-A1811 trials Research Report on Shr-A1811

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP
Trastuzumab Rezetecan - Breast Cancer, HER2-positive Breast Cancer
Phase 4Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University592026-05-312026-05-15

Conditions studied

Breast Neoplasms (1)

Sponsors

The First Affiliated Hospital with Nanjing Medical University (1)